-
关于我们
Proji Company was founded in August 2004. It is a high-tech research and development enterprise established by returned overseas students, undertaking the task of industrializing and transforming various scientific research projects. -
Scientific research technology
Scientific research technology
科研技术
Proji Company is a constituent unit of the "National Engineering Research Center for Protein Technology" of Tsinghua University. It is the first national engineering laboratory established by the National Development and Reform Commission at Tsinghua University. Former President of the Chinese Academy of Sciences, Zhou Guangzhao, and the "Father of DNA", Nobel laureate James D. Watson served as honorary directors of the laboratory, with Professor Luo Yongzhang serving as the director. -
Products
公司产品
For nearly two decades, Proji Company has been primarily engaged in the development and production of recombinant protein drugs, antibody drugs, and in-vitro diagnostic reagents. It has established a unique R&D and large-scale preparation technology platform for recombinant protein drugs that has reached international standards. -
Project
项目公司
The company has long received strong support from various levels of government, including the National Development and Reform Commission, the Ministry of Science and Technology, and the municipal governments of Beijing, Yantai, Shenzhen, and Changzhou. -
新闻资讯
The company's marketing network spans 18 provinces and cities across the country (including 6 provinces and cities covered by medical insurance), benefiting more than 4 million patients, and gradually growing into a new benchmark in the biopharmaceutical industry. -
职业发展
From small-scale research institutions to advanced biopharmaceutical bases, the company's marketing network spans 18 provinces and cities across China.
During his inspection tour of Yantai Proji Pharmaceutical Technology Co., Ltd., Jiang Cheng emphasized the importance of independent innovation, accelerated transformation of scientific and technological achievements, maintaining strategic focus, and achieving steady development.
Published Time:
2025-07-30 09:46
7 Month 29 On the morning of the day, Jiang Cheng, a member of the Standing Committee of the Shandong Provincial Committee and Secretary of the Yantai Municipal Committee, went to Yantai Proji Pharmaceutical Company for investigation. Luo Yongzhang, director of the National Engineering Research Center for Protein Technology and professor at Tsinghua University, and Luo Liang, chairman of Proji Company, participated in the symposium.
The meeting listened to Professor Luo's report on the recombinant albumin project. Secretary Jiang Cheng emphasized that it is necessary to deeply study and implement General Secretary Xi Jinping's important expositions on the development of the biopharmaceutical industry, adhere to independent innovation, accelerate the transformation of achievements, release scale effects, and inject strong impetus into the high-quality development of the city's biopharmaceutical industry. News link is as follows:
https://mp.weixin.qq.com/s/vT6vHSiR0YsxSWAANb7fmw 
Previous Page
Related Recommendations
Beijing Protgen Biotechnology Development Co., Ltd.
Tel:86010- 6297 9258
Postcode: 100085
Email:protgen@protgen.com
Address: No. 32, Chuangye Zhonglu, Haidian District, Beijing
Official Account QR Code
Maintenance Department QR Code
copyright © 2024 Beijing Progen Biotechnology Development Co., Ltd. Powered by：CEglobal TagsFriendly Links:Tsinghua UniversityNEC